These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33855071)

  • 1.
    Mustafa G; Mahrosh HS; Arif R
    Biomed Res Int; 2021; 2021():5538535. PubMed ID: 33855071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF11 antagonizes TNF-α-induced inflammation and protects against the development of inflammatory arthritis in mice.
    Li W; Wang W; Liu L; Qu R; Chen X; Qiu C; Li J; Hayball J; Liu L; Chen J; Wang X; Pan X; Zhao Y
    FASEB J; 2019 Mar; 33(3):3317-3329. PubMed ID: 30407878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for potency differences between GDF8 and GDF11.
    Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB
    BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
    McCoy JC; Walker RG; Murray NH; Thompson TB
    J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes.
    Varas A; Valencia J; Lavocat F; Martínez VG; Thiam NN; Hidalgo L; Fernández-Sevilla LM; Sacedón R; Vicente A; Miossec P
    Arthritis Res Ther; 2015 Jul; 17(1):192. PubMed ID: 26215036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera.
    Matsuno H; Yudoh K; Katayama R; Nakazawa F; Uzuki M; Sawai T; Yonezawa T; Saeki Y; Panayi GS; Pitzalis C; Kimura T
    Rheumatology (Oxford); 2002 Mar; 41(3):329-37. PubMed ID: 11934972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial IL-21/TNF-producing CD4
    Lebre MC; Vieira PL; Tang MW; Aarrass S; Helder B; Newsom-Davis T; Tak PP; Screaton GR
    J Leukoc Biol; 2017 Mar; 101(3):775-783. PubMed ID: 27733582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle.
    Lian J; Walker RG; D'Amico A; Vujic A; Mills MJ; Messemer KA; Mendello KR; Goldstein JM; Leacock KA; Epp S; Stimpfl EV; Thompson TB; Wagers AJ; Lee RT
    Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36631218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway.
    Liu XR; Li SF; Mei WY; Liu XD; Zhou RB
    Chin J Integr Med; 2024 Apr; 30(4):299-310. PubMed ID: 38212502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing a new bispecific tandem single-chain variable fragment antibody against tumor necrosis factor-α and interleukin-23 using in silico studies for the treatment of rheumatoid arthritis.
    Barkhordari A; Mahnam K; Mirmohammad-Sadeghi H
    J Mol Model; 2020 Aug; 26(9):225. PubMed ID: 32778954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-Related Differences in BMP Expression and Adult Hippocampal Neurogenesis within Joint-Hippocampal Axis in a Rat Model of Rheumatoid Arthritis.
    Omrčen H; Zoričić Cvek S; Batičić L; Šućurović S; Grubić Kezele T
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.
    Tas SW; Vervoordeldonk MJ; Hajji N; May MJ; Ghosh S; Tak PP
    Arthritis Res Ther; 2006; 8(4):R86. PubMed ID: 16684367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
    Buchan G; Barrett K; Turner M; Chantry D; Maini RN; Feldmann M
    Clin Exp Immunol; 1988 Sep; 73(3):449-55. PubMed ID: 3264773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytes.
    Takahashi S; Inoue T; Higaki M; Mizushima Y
    Drugs Exp Clin Res; 1998; 24(2):67-71. PubMed ID: 9675546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antcin K Inhibits TNF-α, IL-1β and IL-8 Expression in Synovial Fibroblasts and Ameliorates Cartilage Degradation: Implications for the Treatment of Rheumatoid Arthritis.
    Achudhan D; Liu SC; Lin YY; Huang CC; Tsai CH; Ko CY; Chiang IP; Kuo YH; Tang CH
    Front Immunol; 2021; 12():790925. PubMed ID: 34975889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.